In order to determine optimal conditions for the clinical application of leukocyte acid sialidase determination, we have studied some characteristics of the enzyme giving attention more specifically to the enzyme's thermolability and the influence of potential effectors.
Introduction
Methylumbelliferyl-N-acetyl-a-O-neuraminic acid, a fluorimetric Substrate for sialidase (EC 3.2.1.18) was synthesized by Polier et al. (1) , Werner & O'Brien (2) , and Eschenfelder (3) .
Since the enzyme cannot be measured in plasma (results not shown), we have studied the leukocyte enzyme characteristics in order to find optimal conditions for the determination. The assay of this enzyme is useful for fast biochemical investigation of suspected cases of sialidosis, a disease characterized by a sialidase deficiency.
The effect on sialidase of the time lapse between blood sampling and Isolation of the leukocytes was examined and attention was focused on enzyme stability at different temperatures between -20 °C and +50 °C and the influence of albumin and detergents.
Since the fluorescent end product of the reaction is measured by simple alkalization, this method has permitted the investigation of possible Inhibition by other substances containing terminal sialic acid (and therefore used in colorimetric sialidase determinations), without colour development interference.
Materials and Methods

Chemicals
Methylumbelliferyl-N-acetyl-a-D-neuraminic acid was prepared by Mrs. U. Rose, Heidelberg. Sodium acetate, sodium carbonate, sodium hydrogencarbonate, potassium phosphate and Triton Χ-Ι 00 were obtained from Merck, Darmstadt, W. Germany. Sialyllactose, fetuin III and IV, mucin, colominic acid, albumin and sodium taurocholate were purchased from Sigma, St. Louis, MO, USA. Methoxyphenyl-N-acetylneuraminic acid was a gift from the National Institute of Allergy and Infectious Diseases, NIH, Bethesda, MD, USA.
Isolation of leukocytes and homogenate preparation
Leukocytes were isolated from 20 ml of heparinized blood by Sedimentation (generally between l and 3 hours) at room temperature followed by two washings with isotonic saline. In general, contamination by ced blood cells was minimal and lysis of the remaining red blood cells was obtained by adding 0.3 ml of distilled water for 20 seconds and restoring the normotonicity immediately by adding a 30 times greater volume of isotonic saline. Cold bU distilled water (0.5 ml) was added to the pellet and homogenization of the cells was achieved during exactly 30 seconds in a Potter-Elvejehm vessel kept in ice. In this procedure, no estimation of cellular destruction or cell count was performed, because activity was expressed per mg protein. The extract was used immediately for measuring the enzyme catalytic activity unless otherwise stated.
In other experiments, we tested the effect of mechanical forces by homogenizing a pellet during different times from short periods up to 5 minutes, taking repeat samples for catalytic activity measurement. Pipettable homogenates could be obtained after a 5 seĉ ond homogenization period and the enzyme activity in this homogenate was therefore used s the 100% reference. The homogenization was then continued while taking repeat homogenate samples. With increasing times of homogenization pipetting bccame easier. An arbitrary period of 30 seconds was therefore established s the Standard method of homogenate preparation.
Enzyme determination
Protein was determined according to Lowrytt al. (4) . Acid siall· dase was measured s follows: In small glas tiioes (internal diameter 0.3 cm, length 3 cm) 10 μΐ of leukocyte homogenate togethef with 2 μΐ of l mol · l" 1 sodium acetate buffer pH 4 and 10 μΐ of 0.2 mmol · Γ 1 Substrate (total volume 22 μΐ) were incubated at 37 °C for 15 and 30 min. Substrate blanks with buffer were incubated separately. The reaction was stopped with 0.250 ml of 0.5 mol · Γ 1 sodium carbonate-hydrogen carbonate pH 10.7 and homogenate was added to the blanks, The fluorescence was read in the high sensitivity sample holder of the Turner fluorimeter using excitation and emission wavelengths of 360 and 460 nm respectively.
The pH activity curve was deteffnined by the routine test, using l mol · Γ 1 sodium acetate pH 3-6, and l mol · l" 1 potassium phosphate pH 6.5 and 7.
For the thermolability studies, either total blood or plasma containing the leukocytes was kept at room temperature, and sialidase was determined at different times up to 8 hqurs after the blood drawing, without and with albumin (final concentration 5 g/l). In a second set of experiments, leukocyte homogenates were kept at different temperatures (0, 23, 37, 50 °C) for up to 8 hours and the enzyme activity measured at regul r time intervals. In another series of experiments, either leukocyte pellets or homogenates were kept frozen at -20°C, Therefore either intact leukocytes were frozen under a small amount of physiological saline or the leukocyte homogenate was transferred to small stoppered glass tubes immediately after homogenization and stored at -20 °C. The homogenate was unfrozen only once at the time of the enzyme determination which was carried out in the same tube.
For the Inhibition studies, graded amounts of potential Inhibitors (maximal final test concentration in parentheses) such s sialyllactose (0.5 g/l), fetuin III and IV, mucin, colominic acid (each 1.15 g/l), Triton X-100 (2 g/l), Na-taurocholate (10 g/l) and methoxypheHyl^N-acetylneuraminic acid (6 g/l) were added to the incubation medium.
Results
The pH activity curve shows an Optimum at 4 ( fig.  1 ). The protein concentration of the homogenates varied between 3 and 17.6 g/l. For the thermolability studies, the protein concentration was 10 g/l.
Residual activity of sialidase was unchanged after an homogenization period up to 30 seconds. After l, 2, 3 and 5 minutes, the activity dropped to 91, 73, 60 and 0% respectively.
The use of a dense leukocyte homogenate allows short incubation times of 15 and 30 minutes so that strict reaction line rity and minimal non-enzymatic Substrate hydrolysis was obtained.
Using 10 samples, normal catalytic activities between 1.10 and 6.50 nmol of Substrate hydrolysed per hour and per mg protein (mean value of 2.23) were obtained with a coefficient ot Variation within 10%. Either total blood or leukocyte containing plasma was kept at 23 °C and the catalytic activity of sialidase determined at fixed intervals of l, 2, 4 and 8 hours. No difference was observed between plasma or total blood, and a time-dependent loss of activity of the supposedly intact intralysosomal sialidase was observed. After 2 and 8 hours, a residual catalytic activity of 72 and 50% respectively remained (total number of 8 samples assayed). In a second series of experiments on the influence of temperature, we noted that after 8 hours at 0°C, there is a recuperation of 90% of the enzyme in leukocyte homogenates, but the residual catalytic activity dropped to about 50% after the same period at 23 °C and the total enzyme aetivity was lost after 4 hours at 37 °C arid 10 min at 50 °C. When we added albumin (final concentration pf 5 g/l) to the homogenate there was marked enzyme prptection with retardation of inactivation at 23 and 37 °C ( fig. 2 ).
After an 8 weeks storage period of pellets at -20 °C, the residual activity was approximately 40%. On the pther band, when determinations were carried out on homogenates kept under the same conditions, the mean value was 50%. All substances tested indeed inhibit the enzyme to variable degrees, with a high Inhibition by methoxyphenyl-N-acetylneuraminic acid, another sialidase Substrate ( fig. 3 ). 
Discussion
The fluorimetric sialidase determination with this Substrate was first introduced by Potier (l, 6, 7) and in a previous paper we described the measurement of acid sialidase in cultured fibroblasts (8) .
For the study of leukocyte sialidase, most authors have used leukocyte extracts made either by sonication or homogenization (l, 6-10). Since mechanical homogenization is an acceptable method for making leukocyte extracts with expression of the results per mg protein, we did not perform cell counts. For the isolation of the leukocytes, we have found that the catalytic activity of sialidase (per mg protein) is approximately 50% when dextran Sedimentation of the leukocytes is used instead of simple Sedimentation, but we have not further examined the reasons for this discrepancy. This observation however Stresses the importance of using a standardized isolation procedure. The use of intact leukocytes instead of homogenates has been advocated by Kuriyama et al. (11) because loss of activity can occur during homogenization. It is not understood at the present time whether Substrate can either penetrate the lysosomes or if there is partial rupture of the lysosomal and cellular membrane in the incubation mixture with subsequent release of enzymes into the medium. In our hands, no diminished activity was observed when the pellet was homogenized during short periods at 0°C. Intact leukocytes äs well äs homogenates lend themselves to sialidase determination äs long äs a strictly standardized procedure is followed for isolation and homogenization.
The pH 4 Optimum of the enzyme corresponds to that of a sedimentable leukocyte sialidase, which is also optimally active at this pH with sialyllactose äs the Substrate (12). Published pH optima using the same fluorescent Substrate (l, 9) are very similar, although somewhat less acidic (between pH 4.2 and 4.5). This acid pH Optimum makes it reasonable to assume that the enzyme normally functions within lysosomes although this hypothesis has not been strictly proven.
The K m value of 0.25 mmol · 1 is in very close agreement with the results of Potier (1) and Marchesani (9) . Using labeled sialyloligosaccharides, sialidase has also been determined in leukocytes by Kuriyama et al. (11) and Strecker et al. (13) and K m values between 1.5 and 4.5 mmol-1 were obtained 1 ). Owing to Substrate scarcity, the initial sub-] ) Dependence of the K m value on Substrate concentration is due to the fact that higher concentrations of methylumbelliferyl-Nacetyl-a-D-neuraminic acid inhibit the enzyme äs we have found with other sialidases.
strate concentration used was about 0.1 mmol -1" 1 . Since methylumbellifefyl-N-acetyl-a-D-neuraminic acid is now commercially available (Koch Light, Suffolk, England), we recommend final concentrations of 0.5 mmol · 1 (about twice the K m value), thus avoiding Substrate Inhibition, high blank values and the high cost of Substrate.
The observation of the gradual loss of enzyme activity when a blood sample was kept at room temperature makes it imperative to isolate leukocytes äs soon äs possible, preferably immediately after blood drawing.
On the other band, the enzyme stability at 0 °C contrasts with the fibroblast sialidase which looses most of its activity during the same period of time (8) . Thus, it can be conclüded that determinations done on leukocyte homogenates which have been kept in ice for some time are reliable. However, we have further observed that sialidase is inactivated when homogenates are kept at room temperature or 37 °C, while a few minutes at 50 °C suffices to completely inactivate the enzyme. this inactivation can be partially prevented by adding albumin, äs noted previously for fibroblast sialidase (8) . In the routirie test no addition is necessary, because the short incubation time allows the reaction to proceed linearly. On the basis of therinolability and other parameters, such äs pH Optimum and the effect of octyl-ß^glucoŝ ide, two sialidase fractions have been described in human leukoeytes (7) .
Sialidase in intact leukocytes : pr -homogenates is equally inactivated when kept at -20 °C, although we have obtained some higher values for residual activity than previöusly reported (9), probably because we have thawed each homogenate only once at the time of enzyme determination. According to Suzuki et al. (10) , normal leukocytes contain a freeze-labile and freeze-stable component. The latter amounts to approximately 25-35% of the total catalytic activity and would represent the remaining activity in adult patients with ß-galactosidase^sialidase deficiency. We have reported previously on the deficiency of leukocyte acid sialidase in a patient with the chefry red spot myoclonus syndrome (8) .
From figure 3 , it is clear that all substances tested indeed inhibit the enzyme to variable degrees. The Inhibition by sialyllactose and by fetuin, in concentrations comparable to those used for £olorimetric oligösaccharide or glycoprotein sialidase assays with the same substances, is only minimal. In contrast, methioxyphenyl-N-acetylneuraminic acid (another sialidase Substrate) is a potent Inhibitor and has a remarkable effect even at low cotfcentrations. 1t is not unexpected that bovine submaxillary mucin and colomjnic acid are also inhibitory because they contain N-acetylneuraminic acid, which is terminally linked 2' -> 6' in the first compound and 2' -> 8' in the latter homopolymer. The last Substrate has also been used recently to investigate some characteristics of the enzyme (14) . Except for methoxyphenyi-N-acetylneuraminic acid, Triton X-100 and sodium taurocholate have the highest inhibitory effect Using the same Substrate, a comparable Inhibition by Triton X-100 was reported (9); other effectors, such äs CaCt and N-acetylneuraminic acid, have also been studied (1) . With sialyllactose äs Substrate, the inhibitory effect of Triton X-100, deoxycholate and a series of Chloride salts, has also been reported (12) .
Conclusion
The clinical detennination of leukocyte sialidase is feasible if some precautions are taken. It is important that the leukocytes are isolated without delay after the blood drawing. Either fresh leukocytes in toto or dense extracts can be used. In the latter case, the homogenization time should be short, the homogenate dense and the procedure itself and subsequent handling of the homogenate done at 0 °C and incubation times should not exceed 30 minutes. No albumin addition is necessary, since Substrate protection allows reaction linearity.
